TRINEX Tablet is a trusted hemostatic agent containing Tranexamic Acid, available in doses such as 500 mg or 650 mg depending on clinical application. Developed by BluepillExpress, a reputed name in global pharmaceutical third-party manufacturing and exports, this tablet is formulated to deliver reliable antifibrinolytic action, ensuring controlled and efficient management of bleeding disorders.

Tranexamic Acid works by inhibiting the activation of plasminogen to plasmin, thereby preventing fibrin degradation and stabilizing blood clots. It is particularly useful in conditions where excessive fibrinolysis is the root cause of bleeding. As a non-hormonal treatment, it is widely preferred in menorrhagia, epistaxis, tooth extractions, and various surgical or trauma-related bleeding conditions.

Manufacturing Excellence by BluepillExpress:

TRINEX Tablet is produced in WHO-GMP, ISO 9001:2015, and cGMP certified facilities, strictly following Schedule M guidelines. Each batch undergoes meticulous quality checks, including:

Assay and content uniformity testing

Dissolution profiling

Microbial limit tests

Residual solvent analysis

Packaging integrity validation

These robust protocols ensure the purity, potency, and bioavailability of every TRINEX Tablet manufactured for local and international markets.

Pharmacological Profile:

Tranexamic Acid is a synthetic antifibrinolytic agent that exerts its effect by blocking lysine binding sites on plasminogen molecules, thereby reducing the dissolution of fibrin clots. This makes it effective for a wide range of bleeding scenarios without affecting platelet count or clotting time.

Indications:

Heavy menstrual bleeding (Menorrhagia)

Bleeding associated with dental procedures in hemophilia

Epistaxis (nosebleeds)

Postpartum hemorrhage

Surgical bleeding (orthopedic, gynecological, cardiac, etc.)

Hereditary angioedema (off-label use)

Trauma-related internal bleeding (with medical supervision)

Dosage & Administration:

Menorrhagia: 500 mg to 1000 mg three times daily for up to 5 days

Surgical bleeding prevention: 1000 mg prior to surgery, then 3-4 times daily post-op

Dental extraction in hemophiliacs: As per specialist recommendation

Note: Dosage should be customized by a healthcare professional based on the bleeding condition, renal function, and patient history.

Why Choose TRINEX Tablet by BluepillExpress:

Non-hormonal treatment for menstrual bleeding

No interference with ovulation or fertility

Minimizes need for blood transfusion postoperatively

High oral bioavailability and gastric tolerability

Bulk manufacturing and custom branding available

Product Packaging & Export-Ready Compliance:

BluepillExpress offers TRINEX in blister or strip packing, typically:

10 tablets per strip

Aluminum-PVC or Alu-Alu packaging

Multilingual labels and patient information leaflets

Compliant with country-specific registration and regulatory needs

With international experience in supplying to Asia, Africa, CIS, Middle East, and Latin America, BluepillExpress ensures complete documentation including:

Certificate of Analysis (COA)

Certificate of Pharmaceutical Product (COPP)

MSDS

Stability Data

Product Dossier (CTD/eCTD format on request)

Precautions & Contraindications:

Use with caution in patients with renal impairment (dose adjustment required)

Not recommended in patients with active thromboembolic disease

May cause mild side effects like nausea, diarrhea, headache, or visual disturbances

Avoid in patients with a history of seizures